Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5563
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRashmita Pradhan-
dc.date.accessioned2026-07-03T07:23:29Z-
dc.date.available2026-07-03T07:23:29Z-
dc.date.issued2026-07-03-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5563-
dc.descriptionVol. 163, No. 2, p 166en_US
dc.language.isoenen_US
dc.subjectBiomarkeren_US
dc.subjectMild cognitive impairmenten_US
dc.subjectNon-progressoren_US
dc.subjectProgressoren_US
dc.subjectSuface plasmon resonanceen_US
dc.titleBlood level of β-amyloid, Tau, and p*Tau in mild cognitive impairment and Alzheimer disease : A follow up stidyen_US
dc.typeOtheren_US
Appears in Collections:Vol. 163, No.2, 2026

Files in This Item:
File Description SizeFormat 
1.jpegVol. 163, No. 2, p 166213.03 kBJPEGView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.